Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q3 2024 Cardiology Update

Skip to the end of the Expertise Menu

Q3 2024 Cardiology Update

The cardiology sector saw a few notable transactions close in the third quarter of 2024, including two transactions closed by Provident. Established cardiology platforms have continued to show an appetite for new market expansion through partnerships with sizeable groups and through add-on acquisitions of in-state practices.

Provident is aware of multiple cardiology deals that are in process across the country with incremental deal closings expected in Q4. While transaction activity will undoubtedly slow down from the fury of closings in the initial quarters of platform formation and expansion, large independent cardiology practices will continue to command high valuations given their scarcity in the market and the number PE-backed MSOs already established in the specialty.

To print and download the full Cardiology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/10/Q3-2024-Cardiology-Newsletter_vF.pdf“” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]